10亿+2亿英镑投资接连撤出!英制药业遭重挫

经济日报
Sep 22

今日主播孙昌岳:近来,英国制药行业接连遭遇重挫。先是默沙东取消在英国的10亿英镑扩张计划,随后阿斯利康也宣布暂停其在剑桥研发基地2亿英镑的投资。这一系列动向反映出英国创新生态吸引力正在减弱。自脱欧以来,英国药品审批效率有所放缓,人员流动限制也给科研合作带来一定影响。与此同时,英国药品支出在国民医疗服务体系中的预算占比持续走低,目前已降至9%,明显低于其他发达国家14%至20%的水平,削弱了企业的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10